The global market for tensiometer is primarily driven by the need to improve product quality and manufacturing processes, increasing pharmaceutical and biopharmaceutical R&D expenditure, and technological advancements. However, the reluctance to switch from conventional methods and a dearth of skilled personnel will challenge market growth.According to the new market research report “Tensiometer Market by Product (Optical, Force, Volumetric, Bubble Pressure Tensiometer, Accessories), Industry (Chemical, Oil & Gas, Energy, Pharmaceutical, Medical Devices, Cosmetics, Research Laboratory), Region - Global Forecast to 2024", published by MarketsandMarkets™ expected to reach USD 151 million by 2024 from an estimated value of USD 103 million in 2019, growing at a CAGR of 7.9% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10015314
Global Tensiometer Market Segmentation:1. On the basis of product, the tensiometer market is segmented into optical tensiometers, force tensiometers, volumetric tensiometers, bubble pressure tensiometers, and accessories. The optical tensiometers segment accounted for the largest market share in 2018.2. On the basis of industry, the tensiometer market is segmented into chemical, oil & gas, energy, pharmaceutical & biopharmaceutical, medical device, cosmetic, and other industries (food & beverage, materials & composite, textile, and paper & packaging industries).Asia Pacific accounted for the largest share of the tensiometer market in 2018The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, Asia Pacific accounted for the largest share of the tensiometer market. The factors such as chemical production growth in China, growth in Indian oil & gas industry, increasing demand for primary energy in India, and growth in medical device & pharmaceutical market in Asia are driving the growth of the tensiometer industry in this region.
Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=10015314
Key Market Players :The key players in the global tensiometer market are KRÜSS GmbH (Germany), DataPhysics Instruments GmbH (Germany), Biolin Scientific AB (Sweden), Kyowa Interface Science Co. Ltd. (Japan), LAUDA Scientific GmbH (Germany), TECLIS Scientific (France), Apex Instruments Co. Pvt. Ltd. (India), Pro-Pack Materials (Singapore), USA KINO Industry Co. Ltd. (US), and Kibron Inc. Oy (Finland).
According to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.
Early buyers will receive 10% customization on reports :https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889
In this report, the market is segmented by tool, technology, application, and region. On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to grow at the highest rate during the forecast period. The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.Browse and in-depth TOC on “Synthetic Biology Market”162 - Tables32 - Figures214 - PagesGet Bundle Reports @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.htmlKey players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US). These players are increasingly collaborating, and partnering with companies to offer their synthetic oligonucleotides and to develop synthetic organisms.
The global transfer membrane market is expected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of market.According to the new market research report " Transfer Membrane Market by Type (PVDF, Nitrocellulose, Nylon), Transfer Method (Tank, Semi-dry, Dry), Application (Western, Northern, Southern Blot, Protein Sequencing), End user (Academia, Diagnolab, Pharmaceutical Companies) - Global Forecast to 2023" the transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36975865
This research study involved the usage of extensive secondary sources, directories, and databases such as D&B, Bloomberg Business, and Factiva, along with government databases, to identify and collect information useful for this technology-based, market-oriented, and commercial study of the transfer membrane market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects.
Objectives of the study are:1. To define, describe, and forecast the market by type, transfer method, application, end user, and region2. To provide detailed information regarding the major factors influencing market growth (drivers, restraints, and opportunities) along with the current trends3. To strategically analyze micromarkets with respect to their individual growth trends, prospects, and contributions to the total market4. To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players5. To forecast the revenue of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa6. To profile the key players and comprehensively analyze their market shares and core competencies7. To track and analyze competitive developments such as acquisitions and expansions in the marketGet Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=36975865The report analyzes the global market by type, transfer method, application, end user, and region.On the basis of type, the market is divided into nylon membranes, nitrocellulose membranes, and PVDF membranes. In 2018, PVDF Membranes are expected to command for the major share of the market. This can be attributed to the advantages of PVDF membranes over its counterparts, such as better protein retention, strength, chemical compatibility, and wide applications in western blotting.Based on end user, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Among these, the academic and research institutes segment is expected to account for the largest share of the transfer membrane market in 2018, owing it to the rising financial support from private as well as government bodies for life science research in various nations.This report covers the market data across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global transfer membrane market in 2018, followed by Europe.Want Full Report? Inquire Here: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=36975865
The liquid filter integrity test segment accounted for the largest share of the global filter integrity test market in 2018.According to the new market research report "Filter Integrity Test Market by Test Type (Bubble Point, Diffusion, Water Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics) - Global Forecast to 2024", The market for filter integrity test is projected to reach USD 79 million by 2024 from USD 59 million in 2018, at a CAGR of 5.0% during the forecast period.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46873904
Filter Integrity Test Market is segmented into following types:# Based on type, the market is segmented into diffusion test, water flow integrity test, and bubble point test. In 2018, the diffusion test segment accounted for the largest share of the filter integrity test market. This segment is also expected to witness the highest growth during the forecast period.# Based on mechanism, the filter integrity test market is segmented into automated and manual filter integrity tests. Integrity tests based on the automated mechanism accounted for the larger share of the market in 2018.# Based on end user, the filter integrity test market is segmented into pharmaceutical and biopharmaceutical companies, CMOs, and other end users.Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=46873904Some of The Major Players in Filter Integrity Test Market :1. Merck KGaA (Germany)2. Danaher Corporation/Pall Corporation (US)3. Sartorius (Germany)4. Donaldson Company (US)5. Parker Hannifin Corporation (US)6. Meissner Filtration Product (US)7. MDI Filtration Technologies (US)8. Thermo Fisher Scientific (US)9. Eaton Corporation (Ireland)The market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the market, followed by Europe. The increasing demand for biopharmaceuticals and implementation of drug safety guidelines by the FDA are the major factors driving the growth of the filter integrity test industry in North America.
According to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology. This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889
Synthetic Biology Market segmented into :+ The global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.+ By technology, the market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology.+ The market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application.Want Full Report? Inquire Here: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=889What Drives the Market?1. Wide Range of Applications of Synthetic Biology2. Rising R&D Funding and Initiatives in Synthetic Biology3. Increasing Demand for Synthetic Genes and Synthetic Cells4. Increasing Investments in Synthetic Biology CompaniesGeographical Growth Analysis:The market in Europe is expected to register the highest growth rate from 2017 to 2022. The rising international alliances between the European countries and other countries and heavy funding from the government to foster the synthetic biology research in Europe are major factors driving the growth of market in this region. Additionally, factors such as increasing investments for the adoption of novel synthetic biology technologies, rising R&D funding and collaborations are driving the growth of the market in this region.Key Players and Strategies Adopted by Them:Key players in the global Synthetic Biology Market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US). These players are increasingly collaborating, and partnering with companies to offer their synthetic oligonucleotides and to develop synthetic organisms.
The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022.The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42710391
High Content Screening Market is segmented into following types:* High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner. High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.* Based on product, the global market is broadly segmented into instruments, consumables, software, services, and accessories. The market for HCS software is expected to grow at the highest CAGR between 2017 and 2022. Among all high content screening products, instrument segment caters to the largest share. The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=42710391Some of The Major Players In High Content Screening Market :1. GE Healthcare (U.S.)2. Danaher Corporation (U.S.)3. Thermo Fisher Scientific, Inc. (U.S.)4. PerkinElmer, Inc. (U.S.)5. Tecan Group (Switzerland)6. BioTek Instruments Inc. (U.S.)7. Becton, Dickinson and Company (U.S.)8. Bio-Rad Laboratories (U.S.)The factors expected to drive the growth of the market are rising need for cost containment in pharmaceutical R&D, growth in funding for cellular research, and technological advancements in HCS solutions during the forecast period. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine offer significant growth opportunities in the HCS market. The rising adoption of label-free technologies and growing focus on stem cell analysis are the key trends in the HCS market.
